A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE)
All edits
Edits on 13 Jan, 2024
Golden AI
Edits made to:
Infobox (+15 properties)
Article (+160 characters)
A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE)
Article
Study summary
The reason for this study is to see if the study drug LY3471851 (NKTR-358) is safe and effective in adults with systemic lupus erythematosus (SLE).
Infobox
Is a
NCT Number
Trial Recruitment Size
2910
Trial Sponsor
Clinical Trial Start Date
August 19, 2020
0Primary Completion Date
January 10, 2023
0Study Completion Date
February 16, 2023
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Official Website
Official Name
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358) in Adults With Systemic Lupus Erythematosus0
Last Updated
November 18, 2023
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Double0
Find more entities like A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE)
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.